Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,851 | 51 | 73.1% |
| Consulting Fee | $600.00 | 1 | 23.7% |
| Education | $62.58 | 3 | 2.5% |
| Gift | $19.40 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $826.98 | 6 | $0 (2021) |
| Alcon Vision LLC | $487.57 | 5 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $173.96 | 9 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $153.52 | 4 | $0 (2022) |
| TissueTech, Inc. | $140.21 | 4 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $120.84 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $117.54 | 6 | $0 (2020) |
| ABBVIE INC. | $107.19 | 1 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $75.91 | 5 | $0 (2019) |
| Allergan, Inc. | $62.04 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $445.38 | 4 | Alcon Vision LLC ($236.98) |
| 2023 | $152.44 | 2 | Alcon Vision LLC ($131.49) |
| 2022 | $187.65 | 6 | Alcon Vision LLC ($119.10) |
| 2021 | $285.72 | 12 | Kala Pharmaceuticals, Inc. ($173.96) |
| 2020 | $84.12 | 4 | Sun Pharmaceutical Industries Inc. ($40.92) |
| 2019 | $895.95 | 10 | Aerie Pharmaceuticals, Inc. ($715.22) |
| 2018 | $272.56 | 9 | Novartis Pharmaceuticals Corporation ($99.69) |
| 2017 | $209.46 | 9 | Shire North American Group Inc ($61.60) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2024 | ABBVIE INC. | OZURDEX (Drug), VUITY | Food and Beverage | In-kind items and services | $107.19 | General |
| Category: EYE CARE | ||||||
| 06/20/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $101.21 | General |
| Category: Ophthalmology | ||||||
| 04/29/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $96.04 | General |
| Category: Ophthalmology | ||||||
| 01/12/2024 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $140.94 | General |
| Category: Ophthalmology | ||||||
| 07/26/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: TEPEZZA | ||||||
| 01/12/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $131.49 | General |
| Category: Ophthalmology | ||||||
| 12/07/2022 | Bausch & Lomb Americas Inc. | PROLENSA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Ophthalmology | ||||||
| 11/02/2022 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $98.96 | General |
| Category: Ophthalmology | ||||||
| 10/27/2022 | GLAUKOS CORPORATION | ISTENT INJECT W (Device) | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: GLAUCOMA | ||||||
| 09/12/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Ophthalmology | ||||||
| 06/22/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/30/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Ocular | ||||||
| 11/11/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $62.38 | General |
| Category: Ocular | ||||||
| 10/26/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Ocular | ||||||
| 10/12/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $98.63 | General |
| Category: Glaucoma | ||||||
| 09/22/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Ocular | ||||||
| 07/25/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Ocular | ||||||
| 06/25/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Ocular | ||||||
| 06/09/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Ocular | ||||||
| 05/25/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Glaucoma | ||||||
| 04/22/2021 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: Glaucoma | ||||||
| 04/16/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Ocular | ||||||
| 02/18/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Ocular | ||||||
| 11/13/2020 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), XELPROS, CEQUA | Food and Beverage | Cash or cash equivalent | $22.48 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,778 | 3,707 | $1.2M | $364,367 |
| 2022 | 12 | 2,305 | 3,155 | $952,763 | $303,670 |
| 2021 | 14 | 2,538 | 3,516 | $1.2M | $365,665 |
| 2020 | 11 | 2,150 | 2,986 | $980,883 | $307,930 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 137 | 230 | $529,000 | $105,866 | 20.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 836 | 1,459 | $229,063 | $100,913 | 44.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 693 | 694 | $146,434 | $66,414 | 45.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 188 | 188 | $47,000 | $18,333 | 39.0% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 18 | 24 | $57,600 | $15,388 | 26.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 43 | 50 | $31,250 | $14,745 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $18,000 | $9,451 | 52.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 180 | 183 | $22,875 | $8,878 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 77 | $18,411 | $8,226 | 44.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 147 | 335 | $38,525 | $6,136 | 15.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 151 | 153 | $16,065 | $3,992 | 24.8% |
| 92025 | Ct scan of cornea | Office | 2023 | 138 | 139 | $27,800 | $3,659 | 13.2% |
| 92134 | Imaging of retina | Office | 2023 | 59 | 60 | $6,600 | $1,883 | 28.5% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 13 | 16 | $2,185 | $271.32 | 12.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 27 | 27 | $1,350 | $212.75 | 15.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 825 | 1,429 | $205,073 | $100,315 | 48.9% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 125 | 206 | $473,800 | $95,031 | 20.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 549 | 550 | $108,770 | $52,838 | 48.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 254 | 254 | $59,860 | $27,722 | 46.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 31 | 35 | $21,875 | $9,442 | 43.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 124 | 127 | $15,875 | $5,999 | 37.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 127 | 281 | $32,315 | $5,597 | 17.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 113 | 116 | $12,200 | $2,902 | 23.8% |
| 92025 | Ct scan of cornea | Office | 2022 | 83 | 83 | $16,600 | $2,143 | 12.9% |
| 92134 | Imaging of retina | Office | 2022 | 28 | 28 | $2,970 | $886.02 | 29.8% |
About Dr. Clement Cheng, MD
Dr. Clement Cheng, MD is a Cornea and External Diseases Specialist healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629065826.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clement Cheng, MD has received a total of $2,533 in payments from pharmaceutical and medical device companies, with $445.38 received in 2024. These payments were reported across 56 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,851).
As a Medicare-enrolled provider, Cheng has provided services to 9,771 Medicare beneficiaries, totaling 13,364 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Cornea and External Diseases Specialist
- Other Specialties Ophthalmology
- Location Stanford, CA
- Active Since 10/03/2005
- Last Updated 04/04/2024
- Taxonomy Code 207WX0120X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629065826
Products in Payments
- Rocklatan (Drug) $600.00
- Clareon (Device) $326.49
- INVELTYS (Drug) $173.96
- ARGOS (Device) $140.94
- TRAVATAN Z (Drug) $140.54
- Prokera (Device) $140.21
- Rhopressa (Drug) $115.22
- OZURDEX (Drug) $107.19
- MIEBO (Drug) $101.21
- rocklatan (Drug) $98.63
- XIIDRA (Drug) $74.58
- BROMSITE (Drug) $60.34
- LOTEMAX GEL (Drug) $41.15
- BESIVANCE (Drug) $40.50
- AcrySof (Device) $37.27
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $36.77
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $31.71
- Oxervate (Drug) $29.15
- DURYSTA (Drug) $23.80
- VUITY (Drug) $23.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.